EP4134373 - SYNTHESIS OF DELTA 9,11 STEROIDS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 11.08.2023 Database last updated on 19.10.2024 | |
Former | The application has been published Status updated on 13.01.2023 | Most recent event Tooltip | 27.08.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Santhera Pharmaceuticals (Schweiz) AG Hohenrainstrasse 24 4133 Pratteln / CH | [2023/07] | Inventor(s) | 01 /
Schäfer, Gabriel 4123 Allschwil / CH | 02 /
Olivieri, Lauso 00072 Ariccia / IT | 03 /
Martin, Marco 35031 Abano Terme / IT | [2023/07] | Representative(s) | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstraße 4 80802 München / DE | [2023/07] | Application number, filing date | 21191143.3 | 12.08.2021 | [2023/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP4134373 | Date: | 15.02.2023 | Language: | EN | [2023/07] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 25.05.2022 | Classification | IPC: | C07J71/00, C07J5/00, A61P5/44, A61K31/573 | [2023/07] | CPC: |
C07J71/0015 (EP,IL,KR);
C07J5/0076 (EP,IL,KR);
C07J7/009 (US);
A61K31/573 (KR,US);
A61P5/44 (EP,IL,KR)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/37] |
Former [2023/07] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | 10.08.2023 | ME | 10.08.2023 | Validation states | KH | 10.08.2023 | MA | 10.08.2023 | MD | 10.08.2023 | TN | 10.08.2023 | Title | German: | SYNTHESE VON DELTA-9,11-STEROIDEN | [2023/07] | English: | SYNTHESIS OF DELTA 9,11 STEROIDS | [2023/07] | French: | SYNTHÈSE DE STÉROÏDES DELTA 9,11 | [2023/07] | Examination procedure | 10.08.2023 | Amendment by applicant (claims and/or description) | 10.08.2023 | Examination requested [2023/37] | 10.08.2023 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 30.08.2023 | Renewal fee patent year 03 | 27.08.2024 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]FR1433301 (MERCK & CO INC); | [XI]US3284477 (RAUSSER RICHARD C, et al); | [XDY]EP0969012 (SCHERING CORP [US]); | [XI]CN102040648 (TIANJIN JINYAO GROUP CO LTD); | [XI]CN104974210 (TIANJIN JINYAO GROUP CO LTD); | [Y]CN108191938 (HUNAN XINHEXIN BIOLOGICAL MEDICINE CO LTD); | [X]US2020281942 (MCCALL JOHN [US], et al); | by applicant | US5399727 | EP0969012 |